Novanta Inc. NOVT

143.93 2.40 1.70% as of 25 Sep
Market cap
$5.4B
P/E
90.6×
Growth Flags show if company had growth for consecutive years

Insider Decisions

Total sells 11.57
in millions of $
Nov 25 Feb 26 May 26 Aug 26
Buy — — — — — — — — — — — —
Sell — — 2 4 3 2 1 2 1 1 — 1
Insider Ownership 8.43%

Capital & Financial Ratios

Market Cap 5,350.00
Revenue 1,029.70
Net Income 61.76
Free Cash Flow 109.09
Net Debt (488.99)
Current Ratio 4.57
Debt/Equity 0.14
P/E ratio 90.57
P/S ratio 5.74
P/B ratio 3.65
Past 5Y EPS Growth 8.80%
This Y EPS Growth 12.26%
Next Y EPS Growth 18.23%
Next 5Y EPS Growth 10.09%
in millions of $

Dividends

Payout Ratio 0.00
Annual Dividend Rate —
Annual Dividend Yield —
total individual payouts
2024 Powerpack
2023 Powerpack
2022 Powerpack
2021 Powerpack
2020 Powerpack
2019 Powerpack
2017 Powerpack
predictions in italic, special payouts not included in total or ratios

Assets vs Liabilities

2023 2024 2025 Q'26
Cash 105 114 381 719
Receivables 148 159 194 192
Inventory 149 145 188 193
Other — — — —
415 434 783 1,124
2023 2024 2025 Q'26
Payables 57 77 95 97
ST’ Debt 5 5 38 41
Other — — — —
139 168 212 246
in millions of $

Compound Annual Growth

10y 5y 3y
Sales 10.13% 10.67% 4.43%
Cash Flow 6.72% (14.51%) (10.97%)
Earnings 4.22% 3.87% (10.09%)
Book Value 18.31% 22.48% 31.53%

Revenue

Mar Jun Sep Dec Year
’26 258 266 — — —
’25 233 241 248 258 981
’24 231 236 244 238 949
’23 219 229 222 212 882
’22 204 215 223 218 861
’21 163 168 178 199 707
’20 155 145 143 147 591
in millions of $ · fiscal quarters ending in the months shown

Operating Cash Flow

Mar Jun Sep Dec Year
’26 52 65 — — —
’25 32 15 8 9 64
’24 33 41 23 62 159
’23 10 26 45 39 120
’22 11 24 15 41 91
’21 23 29 14 29 95
’20 18 34 42 47 140
in millions of $ · fiscal quarters ending in the months shown

Free Cash Flow

Mar Jun Sep Dec Year
’26 48 57 — — —
’25 33 12 4 0 48
’24 26 36 19 59 141
’23 7 23 38 33 100
’22 5 18 11 36 71
’21 20 23 8 24 75
’20 15 31 40 43 130
in millions of $ · fiscal quarters ending in the months shown

EPS

Mar Jun Sep Dec Year
’26 0.51 0.30 — — —
’25 0.59 0.12 0.30 0.45 1.47
’24 0.41 0.38 0.53 0.46 1.77
’23 0.51 0.58 0.59 0.35 2.02
’22 0.53 0.49 0.63 0.42 2.06
’21 0.32 0.33 0.38 0.38 1.41
’20 0.34 0.33 0.23 0.35 1.25
fiscal quarters ending in the months shown

Target Price Range

Analyst price targets

Recommendation Rating

1.3
1Buy 2 3Hold 4 5Sell
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028
11.23 20.70 48.40 60.15 66.44 116.55 110.84 111.20 146.86 98.27

Analyst estimates 2026–2028

Powerpack
Low Price
21.75 55.10 78.85 96.31 127.91 184.44 177.11 187.61 187.12 155.39
High Price
1,269 2,034 2,133 2,290 2,200 2,700 3,000 2,900 3,000 3,000
Employees
0 0 0 0 0 0 0 0 0 0
Revenue/Emp
385 521 614 626 591 707 861 882 949 981
Revenue
42.22% 42.30% 42.57% 41.86% 41.40% 42.49% 43.96% 45.36% 44.41% 44.39%
Gross Margin
33 76 61 46 48 56 87 84 79 70
EBT
8.45% 14.60% 9.98% 7.31% 8.20% 7.95% 10.12% 9.50% 8.33% 7.10%
EBT Margin
22 62 51 41 45 50 74 73 64 54
Net Income
20 31 37 38 38 43 53 47 56 62
Depreciation
11.09 14.97 17.60 17.87 16.81 19.97 24.15 24.60 26.40 26.80
Revenue/Sh
0.63 1.14 1.46 1.16 1.27 1.42 2.08 2.03 1.78 1.47
Earnings/Sh
1.38 1.82 2.57 1.81 3.99 2.67 2.55 3.35 4.41 1.75
Cash Flow/Sh
(0.16) (0.26) (0.46) (0.31) (0.30) (0.56) (0.55) (0.56) (0.48) (0.43)
Capex/Sh
1.22 1.56 2.11 1.50 3.69 2.11 2.00 2.79 3.93 1.32
Free CF/Sh
7.46 8.95 10.55 11.91 13.57 14.73 16.20 18.79 20.74 35.92
Book Value/Sh
35 35 35 35 35 35 36 36 36 37
Shares
34.21 43.91 43.52 76.24 93.83 124.18 64.82 80.94 85.83 80.95
PE Ratio
1.94 3.37 3.58 4.95 7.03 8.83 5.58 6.68 5.79 4.44
PS Ratio
2.89 5.64 5.97 7.43 8.71 11.97 8.32 8.74 7.37 3.31
PB Ratio
1.97 3.63 3.78 5.17 7.16 9.28 5.97 6.96 6.10 4.31
EV/Sales
17.87 34.84 31.56 61.65 32.61 87.62 72.15 61.32 41.00 87.21
EV/FCF
48 63 90 63 140 95 91 120 159 64
Op' Cash Flow
(5) (9) (16) (11) (11) (20) (20) (20) (17) (16)
Capex
42 54 74 53 130 75 71 100 141 48
FCF
129 190 178 170 190 190 256 276 266 570
Working Cap'
78 235 207 220 200 434 435 354 417 251
Total Debt
10 135 125 141 75 317 335 249 303 (130)
Net Debt
259 312 368 417 477 521 578 673 746 1,314
Sh' Equity
5.23% 6.91% 7.04% 5.13% 5.13% 4.81% 6.00% 5.91% 4.90% 3.37%
ROA
7.67% 8.07% 8.99% 6.19% 6.33% 4.78% 7.06% 7.48% 6.59% 4.96%
ROIC
8.74% 13.96% 14.97% 10.38% 9.96% 10.09% 13.48% 11.65% 9.03% 5.23%
ROE
predictions in italic, sparklines do not include predictions

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Novanta Inc. peers in Scientific & Technical Instruments

All 34 Scientific & Technical Instruments stocks →

Novanta Inc. (NOVT) key facts

  • Novanta Inc. (NOVT) is a Scientific & Technical Instruments company in the Technology sector, listed on Nasdaq.
  • Novanta Inc.’s revenue for fiscal 2025 (year ended December 2025) was $980.6 million, up 3.30% from fiscal 2024.
  • As of September 25, 2026, NOVT traded at $143.93, a market capitalization of $5.4 billion.
  • Return on equity was 5.23% and debt-to-equity 0.14.

Source: company filings (standardised) and stockrow calculations.

Novanta Inc. (NOVT) Latest News

News by impact score

Fine-tune

19 Sep

3

Novanta (NOVT) shows strong growth and positive demand outlook, prompting assessment of whether the stock represents a bargain at current levels. Strong growth and demand outlook supports moderately positive effects on future financial performance and investor sentiment.

3

Novanta Inc. (NOVT) shows high-margin revenue momentum that may strengthen its competitive moat. Revenue momentum can moderately influence Novanta's competitive positioning and performance outlook.

4 Sep

3

Novanta Inc. posted second-quarter profits that outran sales growth. Q2 profit growth exceeding sales can lift near-term investor views on margins but rarely shifts long-term trajectory.

14 Aug

3

Novanta Inc. discussed five key analyst questions during its Q2 earnings call, covering operational performance, strategic priorities and market outlook. Analyst questions from the Q2 earnings call reveal operational and strategic details that can moderately shape near-term investor views on Novanta.

13 Aug

3 transcript

Novanta Inc. conducted its Q2 2026 earnings call, detailing financial results, operational performance, and forward-looking guidance for investors. Quarterly earnings details typically influence short-term stock sentiment and analyst views without guaranteeing major strategic shifts.

10 Aug

4

Novanta Inc. completed acquisitions and advanced manufacturing initiatives during Q2, resulting in an upgraded company outlook. Acquisitions and manufacturing moves represent major strategic actions likely to shift Novanta's trajectory and investor sentiment.

9 Aug

4

Novanta raised financial guidance and closed its Riverpoint facility, prompting questions on whether the positive moves are already reflected in the stock price. Guidance increase signals stronger future results while Riverpoint closure improves operational efficiency.

8 Aug

4

Novanta closes its largest acquisition. Largest acquisition closure marks a major strategic move with potential to significantly alter company trajectory and investor sentiment.

7 Aug

4 transcript

Novanta Inc posted record cash flow for Q2 2026 and raised full-year guidance. Record cash flow and raised guidance signal stronger financial outlook likely to lift valuation and investor sentiment.

3 transcript

Novanta Inc. (NOVT) shared highlights from its Q2 earnings call covering financial results and operations. Q2 earnings highlights can shift investor views on financial performance and near-term outlook.

6 Aug

3

Novanta Inc. reports increased bookings that reinforce broadening organic momentum across its operations and markets. Increased bookings point to improved future revenue visibility and organic growth for the company.

5 Aug

4

Novanta exceeded Q2 CY2026 sales estimates and issued strong full-year sales guidance. Q2 sales beat paired with upbeat annual guidance signals stronger revenue trajectory and positive investor sentiment.

3

Novanta exceeded Q2 earnings and revenue estimates. Q2 earnings beat may lift near-term stock price and sentiment without altering long-term trajectory.

3

Novanta Inc. announced its financial results for the second quarter of 2026. Quarterly financial results release delivers performance metrics that can shift near-term investor views and trading activity.

27 Jul

4

Novanta Inc. completes acquisition of Riverpoint Medical. Acquisition marks major strategic expansion for Novanta.

9 Jun

4

Novanta Inc. acquires Riverpoint Medical for $1.45 billion. The $1.45 billion acquisition marks a major strategic expansion with significant effects on operations and positioning.

4

Novanta Inc. announces $300 million private placement. $300 million private placement delivers major capital infusion that alters financial structure and investor positioning.

4

Novanta Inc. acquires Riverpoint Medical. Acquisition marks major strategic expansion strengthening Novanta's medical device portfolio and market position.

20 May

3

Novanta reported Q1 results in its earnings call and fielded top analyst questions on financials, growth outlook, margins and market demand. Quarterly earnings call supplies updated guidance and analyst scrutiny that can shift near-term sentiment and valuation but rarely alters long-term trajectory.

16 May

4

Novanta Inc. posts Q1 growth fueled by AI-driven demand and new products, despite ongoing margin pressures. AI demand and new products signal major growth drivers likely to reshape Novanta's trajectory and investor outlook.

15 May

4

Novanta Inc. (NOVT) beat analyst earnings forecasts, prompting analysts to update their models with revised targets. Beating earnings expectations drives positive investor sentiment and analyst upgrades, significantly impacting stock performance and valuation.

13 May

3

Novanta Inc. (NOVT) earnings preview highlights expectations for revenue growth, adjusted EBITDA margins, EPS, and forward guidance amid supply chain issues and market softness in medical and advanced industrial segments. Earnings previews shape investor expectations on financial metrics and guidance, potentially swaying short-term market sentiment without transformative shifts.

12 May

4 transcript

Novanta Inc. (NOVT) released Q1 2026 earnings call transcript detailing financial results, operational updates, and forward guidance. Q1 2026 earnings transcript discloses financial performance and strategic outlook, poised to significantly sway investor sentiment and NOVT's trajectory.

4

Novanta Inc. (NOVT) reported strong revenue growth in Q1 2026 earnings call highlights, navigating geopolitical challenges successfully. Strong revenue growth in Q1 2026 despite geopolitical headwinds signals robust financial performance, likely driving positive investor sentiment and stock trajectory.

4

Novanta Inc. (NOVT) beat earnings expectations and issued stronger-than-expected forward guidance, prompting a detailed valuation reassessment amid positive market implications. Earnings beat and strong guidance shift signal robust financial health and growth prospects, significantly impacting NOVT's valuation and market performance.

4

Novanta Inc. released Q1 earnings call highlights, detailing financial results, revenue growth, profitability metrics, and forward guidance amid strong demand in medical and industrial robotics sectors. Q1 earnings highlights disclose key financial performance and outlook that can drive significant shifts in investor sentiment and stock trajectory.

4

Novanta Inc. released Q1 2026 earnings call summary detailing financial results, segment performance, and forward guidance. Quarterly earnings disclosures shape investor expectations and directly influence stock valuation and trajectory.

11 May

4

Novanta (NASDAQ:NOVT) surprised investors with strong Q1 CY2026 sales results. Q1 sales surprise signals major positive shift in financial performance and boosts investor sentiment.

4

Novanta Inc. announced financial results for the first quarter 2026. Quarterly earnings announcements like Q1 2026 results directly impact financial performance metrics, investor sentiment, and stock trajectory.

3

Novanta Inc. (NOVT) Q1 earnings and revenues surpassed analyst estimates. Q1 earnings beat positively influences financial performance and investor sentiment without fundamentally altering long-term trajectory.

stockrow.com/NOVT · Data as of Jun 30, 2026 · For information only; not investment advice. · © 2026 stockrow.com